Alexander G. Haslberger

Prof. Alexander G. Haslberger

University of Vienna
+1
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Gene
Verified
Journal Article
Closed access
MRMarlene Remely
Marlene Remely
EAEva Aumueller
Eva Aumueller
CMChristine Merold
Christine Merold
SDSimone Dworzak
Simone Dworzak
BHBerit Hippe
Berit Hippe
Alexander G. HaslbergerAlexander G. Haslberger
Alexander G. Haslberger

14 December 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JZJutta Zwielehner
Jutta Zwielehner
CLCornelia Lassl
Cornelia Lassl
BHBerit Hippe
Berit Hippe
APAngelika Pointner
Angelika Pointner
OSOlivier J. Switzeny
Olivier J. Switzeny
Alexander G. HaslbergerAlexander G. Haslberger
Alexander G. Haslberger
We investigated whether chemotherapy with the presence or absence of antibiotics against different kinds of cancer changed the gastrointestinal microbiota. Feces of 17 ambulant patients receiving chemotherapy with or without concomitant antibiotics were analyzed before and after the chemotherapy cycle at four time points in comparison to 17 gender-, age- and lifestyle-matched healthy controls. We targeted 16S rRNA genes of all bacteria, Bacteroides, bifidobacteria, Clostridium cluster IV and XIVa as well as C. difficile with TaqMan qPCR, denaturing gradient gel electrophoresis (DGGE) fingerprinting and high-throughput sequencing. After a significant drop in the abundance of microbiota (p = 0.037) following a single treatment the microbiota recovered within a few days. The chemotherapeutical treatment marginally affected the Bacteroides while the Clostridium cluster IV and XIVa were significantly more sensitive to chemotherapy and antibiotic treatment. DGGE fingerprinting showed decreased diversity of Clostridium cluster IV and XIVa in response to chemotherapy with cluster IV diversity being particularly affected by antibiotics. The occurrence of C. difficile in three out of seventeen subjects was accompanied by a decrease in the genera Bifidobacterium, Lactobacillus, Veillonella and Faecalibacterium prausnitzii. Enterococcus faecium increased following chemotherapy. Despite high individual variations, these results suggest that the observed changes in the human gut microbiota may favor colonization with C.difficile and Enterococcus faecium. Perturbed microbiota may be a target for specific mitigation with safe pre- and probiotics.

1 September 1992 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ATAndrea. Tuschil
Andrea. Tuschil
CLCharles. Lam
Charles. Lam
Alexander G. HaslbergerAlexander G. Haslberger
Alexander G. Haslberger
ILIvan. Lindley
Ivan. Lindley

22 August 2012 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
BSB Stefanska
B Stefanska
HKH Karlic
H Karlic
FVF Varga
F Varga
KFK Fabianowska‐Majewska
K Fabianowska‐Majewska
Alexander G. HaslbergerAlexander G. Haslberger
Alexander G. Haslberger

1 June 2009 in Experimental Gerontology
Verified
Journal Article
Closed access
JZJutta Zwielehner
Jutta Zwielehner
KLKathrin Liszt
Kathrin Liszt
MHMichael Handschur
Michael Handschur
CLCornelia Lassl
Cornelia Lassl
ALAlexander Lapin
Alexander Lapin
Alexander G. HaslbergerAlexander G. Haslberger
Alexander G. Haslberger

1 August 2015 in Beneficial Microbes
Verified
Journal Article
Closed access
MRM. Remely
M. Remely
ITI. Tesar
I. Tesar
BHB. Hippe
B. Hippe
SGS. Gnauer
S. Gnauer
PRPetra Rust
Petra Rust
Alexander G. HaslbergerAlexander G. Haslberger
Alexander G. Haslberger
Genetics, lifestyle, and dietary habits contribute to metabolic syndrome, but also an altered gut microbiota has been identified. Based on this knowledge it is suggested that host bacterial composition tends to change in response to dietary factors and weight loss. The aim of this study was to identify bacteria affecting host metabolism in obesity during weight loss and to correlate them with changes of the body composition obtained from bioelectrical impedance analysis (BIA). We recruited obese individuals receiving a dietary intervention according DACH (German, Austrian, and Swiss Society of Nutrition) reference values and guidelines for ‘prevention and therapy of obesity’ of DAG e.V., DDG, DGE e.V., and DGEM e.V. over three months. Faecal microbiota and BIA measurements were conducted at three time points, before, during, and after the intervention. Gut microbiota was analysed on the basis of 16S rDNA with quantitative real time PCR. Additionally, a food frequency questionnaire with questions to nutritional behaviour, lifestyle, and physical activity was administered before intervention. After weight reduction, obese individuals showed a significant increase of total bacterial abundance. The ratio of Firmicutes/Bacteroidetes significantly decreased during intervention. Lactobacilli significantly increased between the first and the second time point. These differences also correlated with differences in weight percentage. During the intervention period Clostridium cluster IV increased significantly between the second and the third time point. In contrast Clostridium cluster XIVa showed a decreased abundance. The dominant butyrate producer, Faecalibacterium prausnitzii, significantly increased as did the abundance of the butyryl-CoA: acetate CoA-transferase gene. Archaea and Akkermansia were significantly more prevalent after weight reduction. Our results show a clear difference in the gut bacterial composition before and after dietary intervention with a rapid change in gut microbial composition after a few weeks, but also indicate that a major shift requires long term dietary treatment.